Insider Trading activities at Serologicals Corp (SERO)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Serologicals Corp (SERO) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data at Serologicals Corp. Table 2 shows the detailed insider transactions. The reporting company's CIK number is 767673.

Total stock buying since 2005: $0.
Total stock sales since 2005: $681,158.
Total stock option exercises since 2005: $154,615.

▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies


Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Serologicals Corp (SERO).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2006 0 $0 10,475 $257,940 13,435 $154,615
2005 0 $0 31,264 $423,218 0 $0

Table 2. Monthly summary of insider trading at Serologicals Corp (SERO).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2006-03 0 $0 10,475 $257,940 13,435 $154,615
2005-12 0 $0 25,000 $297,625 0 $0
2005-06 0 $0 6,264 $125,593 0 $0

Table 3. Detailed insider trading at Serologicals Corp (SERO)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2006-03-13 Wilcox M Dwain (Vice President) Sale 8,750 24.64 215,643
2006-03-13 Wilcox M Dwain (Vice President) Option Ex 8,750 11.62 101,675
2006-03-13 Gelbman Ronald G (Director) Sale 1,725 24.52 42,297
2006-03-13 Gelbman Ronald G (Director) Option Ex 4,685 11.30 52,940
2005-12-19 Oconnell Desmond H Jr (Director) Sale 25,000 11.90 297,625
2005-06-08 Moufflet Gerard (Director) Sale 6,264 20.05 125,593

Insider trading activities including stock purchases, stock sales, and option exercises of SERO listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Serologicals Corp (symbol SERO, CIK number 767673) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.